# 心血管医疗器械市场

> 心血管医疗器械市场研究报告按器械类型（心脏植入物、诊断成像设备、体外生命支持（ECLS）、外科工具和设备）、按适应症（冠状动脉疾病、心力衰竭、心律失常、瓣膜性心脏病）、按技术（生物可吸收设备、机器人辅助手术、可穿戴监测系统、3D打印）、按最终用户（医院、门诊手术中心、心脏康复设施、居家医疗环境）、按报销模式（按服务收费、打包支付、基于价值的采购、订阅模式）以及按地区-预测至2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.93%
- **2024:** $ 50.72 Billion
- **2025:** $ 52.72 Billion
- **2035:** $ 77.52 Billion
- **Key Players:** Companies such as Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Edwards Lifesciences Corporation (US), Terumo Corporation (JP), Stryker Corporation (US), Cardinal Health (US) are some of the major participants in the Cardiovascular Medical Device Market.

**Report ID:** MRFR/MED/28667-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** May 27, 2026

**URL:** https://www.marketresearchfuture.com/reports/cardiovascular-medical-device-market-30414

---

## Market Summary

## **Cardiovascular Medical Device Market Overview**

As per MRFR analysis, the Cardiovascular Medical Device Market Size was estimated at 50.72 (USD Billion) in 2024. The Cardiovascular Medical Device Market Industry is expected to grow from 52.72 (USD Billion) in 2025 to 74.59 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.93% during the forecast period (2025 - 2034).

### **Key Cardiovascular Medical Device Market Trends Highlighted**

The Cardiovascular Medical Device Market is driven by the rising prevalence of cardiovascular diseases, increasing demand for advanced and minimally invasive treatments, technological advancements, and government initiatives to promote cardiovascular health.

Opportunities for growth lie in the adoption of personalized and remote monitoring technologies, the expansion of markets in developing countries, and the integration of artificial intelligence and machine learning in cardiovascular care.

Recent trends include the shift towards value-based healthcare, the focus on preventive care, and the growing adoption of digital health solutions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Cardiovascular Medical Device Market Drivers**

### **Rising Prevalence of Cardiovascular Diseases**

Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for an estimated 17.9 million deaths in 2019. The prevalence of CVDs is increasing due to factors such as aging populations, unhealthy lifestyles, and rising obesity rates.

This has led to a growing demand for cardiovascular medical devices, which are used to diagnose, treat, and manage CVDs. The Cardiovascular Medical Device Market is expected to grow significantly in the coming years as the prevalence of CVDs continues to rise.

### **Technological Advancements**

Technological advancements are also driving the growth of the Cardiovascular Medical Device Market. New and innovative cardiovascular medical devices are being developed all the time, which offer improved performance, accuracy, and patient outcomes. These advancements are making cardiovascular medical devices more accessible and affordable for patients around the world.

### **Government Initiatives**

Government initiatives are also playing a role in the growth of the Cardiovascular Medical Device Market. Governments are increasingly recognizing the importance of cardiovascular health and are investing in research and development of cardiovascular medical devices.

This support is helping to accelerate the development of new and innovative cardiovascular medical devices, which is benefiting patients around the world.

## **Cardiovascular Medical Device Market Segment Insights**

### **Cardiovascular Medical Device Market Device Type Insights**

The Cardiovascular Medical Device Market segmentation by Device Type comprises Cardiac Implants, Diagnostic Imaging Equipment, Extracorporeal Life Support (ECLS), and Surgical Tools and Equipment. [Cardiac Implants](../../../reports/cardiac-implants-market-6726) held the largest market share in 2023, with a significant contribution to the overall revenue.

The rising prevalence of cardiovascular diseases, technological advancements, and increasing adoption of minimally invasive procedures drive the segment's growth. Pacemakers, defibrillators, and heart valves are the primary products in this category.

Diagnostic Imaging Equipment is another major segment, witnessing steady growth due to the increasing demand for accurate and non-invasive diagnostic techniques. Advanced imaging modalities like Echocardiography, Computed Tomography (CT), and Magnetic Resonance Imaging (MRI) are gaining traction, aiding in the early detection and diagnosis of cardiovascular conditions.

Extracorporeal Life Support (ECLS) plays a crucial role in managing patients with severe heart and lung failure. The segment is projected to expand as the number of critical care cases rises and technological advancements enhance the effectiveness of ECLS devices.

Surgical Tools and Equipment include a wide range of instruments used in cardiovascular surgeries. The growing number of cardiac procedures, coupled with the introduction of innovative surgical techniques, is propelling the segment's growth. Specialized tools, such as robotic-assisted surgery systems and laser devices, are gaining popularity due to their precision and reduced invasiveness.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Cardiovascular Medical Device Market Indication Insights**

The cardiovascular medical device market is segmented by indication into coronary artery disease, heart failure, arrhythmias, and valvular heart disease. Coronary artery disease is the leading cause of death worldwide, and it is estimated that the coronary artery disease market will reach $20.1 billion by 2024.

Heart failure is the leading cause of hospitalization in the United States, and the heart failure market is expected to reach $12.5 billion by 2024. Arrhythmias are disorders of the heart's electrical system, and the arrhythmias market is expected to reach $7.8 billion by 2024.

Valvular heart disease is a condition that affects the heart's valves, and the valvular heart disease market is expected to reach $6.3 billion by 2024.

### **Cardiovascular Medical Device Market Technology Insights**

The Cardiovascular Medical Device Market segmentation by Technology can be divided into Bioresorbable Devices, Robotic-Assisted Surgery, Wearable Monitoring Systems, and 3D Printing. The Robotic-Assisted Surgery segment is anticipated to experience considerable growth over the forecast period, primarily attributed to the rising adoption of minimally invasive surgical procedures.

The Wearable Monitoring Systems segment is also projected to witness significant growth due to the increasing prevalence of chronic cardiovascular diseases and the growing demand for remote patient monitoring solutions.

Moreover, the Bioresorbable Devices segment is expected to gain traction as these devices offer several advantages over traditional implants, such as improved biocompatibility and reduced risk of infection.

### **Cardiovascular Medical Device Market End User Insights**

The end-user segment of the Cardiovascular Medical Device Market is diverse, comprising various healthcare settings where cardiovascular medical devices are utilized to diagnose, treat, and monitor cardiovascular conditions.

Hospitals continue to dominate the market, accounting for a significant share of the Cardiovascular Medical Device Market revenue due to the comprehensive range of cardiovascular services they offer, including advanced diagnostic imaging, surgical interventions, and post-operative care.

Ambulatory surgical centers have gained prominence in recent years, offering specialized cardiovascular procedures in a cost-effective outpatient setting.

Cardiac rehabilitation facilities play a crucial role in post-operative care and long-term management of cardiovascular patients, contributing to the market growth. Home healthcare settings are expanding their scope, providing remote monitoring and support for patients with chronic cardiovascular conditions, leading to increased demand for portable and user-friendly devices.

### **Cardiovascular Medical Device Market Reimbursement Model Insights**

The Cardiovascular Medical Device Market is segmented based on the Reimbursement Model into Fee-for-Service, Bundled Payments, Value-Based Purchasing, and Subscription Models. Fee-for-Service is the traditional reimbursement model, where providers are paid for each service, they provide.

Bundled Payments are a type of value-based reimbursement where providers are paid a fixed amount for a bundle of services related to a specific episode of care. Value-based purchasing is another type of value-based reimbursement, where providers are paid based on the quality and outcomes of the care they provide.

Subscription Models are a newer type of reimbursement model, where patients pay a monthly or annual fee for access to a range of services. Value-Based Purchasing is expected to be the fastest-growing segment, with a CAGR of 4.5% over the forecast period.

This growth is due to the increasing focus on value-based healthcare and the adoption of value-based payment models by governments and private payers.

### **Cardiovascular Medical Devices Market Regional Insights**

The regional segmentation of the Cardiovascular Medical Device Market offers valuable insights into the geographical distribution of market growth. North America holds a significant market share, driven by advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and technological advancements.

Europe follows closely, with a well-established healthcare system and a growing elderly population. APAC is expected to witness substantial growth in the coming years due to rising disposable incomes, increasing healthcare expenditure, and a growing awareness of cardiovascular health.

South America and MEA are emerging markets with significant growth potential, owing to government initiatives to improve healthcare access and rising private sector investments.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Cardiovascular Medical Device Market Key Players and Competitive Insights**

Major players in the Cardiovascular Medical Device Market are continuously involved in strategic collaborations, product launches, and acquisitions to maintain their competitive edge. They are focusing on developing innovative and technologically advanced products to meet the evolving needs of patients and healthcare providers.

The market is characterized by a high degree of competition, with leading Cardiovascular Medical Device Market players such as Abbott Laboratories, Medtronic, Boston Scientific Corporation, Johnson & Johnson, and Siemens Healthineers holding a significant share.

Boston Scientific Corporation, a leading Cardiovascular Medical Device Market player, offers a wide range of products, including stents, catheters, and pacemakers. The company has a strong focus on research and development, which has led to the launch of several innovative products in recent years.

Boston Scientific Corporation's commitment to quality and patient care has earned it a reputation for excellence in the industry.

Another major competitor in the Cardiovascular Medical Device Market is Siemens Healthineers. The company is known for its advanced imaging technologies, such as MRI and CT scanners. Siemens Healthineers also offers a range of cardiovascular medical devices, including stents, catheters, and pacemakers.

The company's strong brand recognition and presence have contributed to its success in the market. Siemens Healthineers is actively involved in strategic partnerships and acquisitions to expand its product portfolio and geographical reach.

### **Key Companies in the Cardiovascular Medical Device Market Include**

- Siemens Healthineers
- Johnson Johnson
- [**Medtronic**](https://www.medtronic.com/in-en/healthcare-professionals/products/cardiovascular.html)
- Terumo Corporation
- Boston Scientific Corporation
- Becton, Dickinson and Company
- Stryker Corporation
- GE Healthcare
- LivaNova PLC
- Edwards Lifesciences Corporation
- Koninklijke Philips N.V.
- Asahi Intecc Co., Ltd.
- Abbott Laboratories
- Jude Medical

## Cardiovascular Medical Device Market Industry Developments

- **Q2 2024: Boston Scientific to acquire Silk Road Medical for $1.2 billion** Boston Scientific announced a definitive agreement to acquire Silk Road Medical, a developer of devices for stroke prevention in patients with carotid artery disease, for $1.2 billion in cash. The deal expands Boston Scientific’s portfolio in the vascular intervention space.
- **Q2 2024: Medtronic wins FDA approval for Symplicity Spyral renal denervation system** Medtronic received FDA approval for its Symplicity Spyral renal denervation system, a device designed to treat hypertension, marking a significant regulatory milestone for the company’s cardiovascular business.
- **Q1 2024: Abbott launches TriClip transcatheter tricuspid valve repair system in Europe** Abbott announced the commercial launch of its TriClip transcatheter tricuspid valve repair system in select European markets following CE Mark approval, expanding its structural heart device offerings.
- **Q2 2024: Shockwave Medical completes acquisition of Neovasc Inc.** Shockwave Medical finalized its acquisition of Neovasc Inc., a company specializing in devices for refractory angina, strengthening Shockwave’s position in the cardiovascular device sector.
- **Q1 2024: FDA approves Edwards Lifesciences’ EVOQUE tricuspid valve replacement system** Edwards Lifesciences received FDA approval for its EVOQUE tricuspid valve replacement system, the first transcatheter therapy for tricuspid regurgitation to be approved in the United States.
- **Q2 2024: CardioSignal raises $15M Series B to expand AI-powered heart disease detection platform** CardioSignal, a health tech startup focused on AI-driven heart disease detection, secured $15 million in Series B funding to accelerate product development and expand its global reach.
- **Q1 2024: Biotronik announces partnership with Mayo Clinic for remote cardiac monitoring** Biotronik entered into a strategic partnership with Mayo Clinic to advance remote cardiac monitoring solutions, aiming to improve patient outcomes through enhanced data analytics and device connectivity.
- **Q2 2024: Philips launches new Azurion image-guided therapy platform for cardiovascular procedures** Philips introduced its latest Azurion platform, designed to support complex cardiovascular interventions with advanced imaging and workflow capabilities, targeting hospitals and specialty clinics.
- **Q1 2024: Terumo opens new manufacturing facility for cardiovascular devices in North Carolina** Terumo announced the opening of a new manufacturing facility in North Carolina dedicated to producing advanced cardiovascular devices, supporting increased demand and expanding its U.S. footprint.
- **Q2 2024: Shockwave Medical completes $200M public offering** Shockwave Medical completed a $200 million public offering to fund further development and commercialization of its intravascular lithotripsy technology for cardiovascular applications.
- **Q1 2024: Boston Scientific announces partnership with HeartFlow to advance coronary artery disease diagnostics** Boston Scientific formed a partnership with HeartFlow to integrate HeartFlow’s AI-powered coronary artery disease diagnostic platform with Boston Scientific’s interventional cardiology solutions.
- **Q2 2024: Abbott appoints new head of global cardiovascular device division** Abbott named Dr. Lisa Chen as the new head of its global cardiovascular device division, signaling a strategic focus on innovation and international expansion.

## **Cardiovascular Medical Device Market Segmentation Insights**

### **Cardiovascular Medical Device Market Device Type Outlook**

- [Cardiac Implants](../../../reports/cardiac-implants-market-6726)
- Diagnostic Imaging Equipment
- Extracorporeal Life Support (ECLS)
- Surgical Tools and Equipment

### **Cardiovascular Medical Device Market Indication Outlook**

- Coronary Artery Disease
- Heart Failure
- Arrhythmias
- Valvular Heart Disease

### **Cardiovascular Medical Device Market Technology Outlook**

- Bioresorbable Devices
- Robotic-Assisted Surgery
- Wearable Monitoring Systems
- 3D Printing

### **Cardiovascular Medical Device Market End User Outlook**

- Hospitals
- Ambulatory Surgical Centers
- Cardiac Rehabilitation Facilities
- Home Healthcare Settings

### **Cardiovascular Medical Device Market Reimbursement Model Outlook**

- Fee-for-Service
- Bundled Payments
- Value-Based Purchasing
- Subscription Models

### **Cardiovascular Medical Devices Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Growing Awareness of Heart Health

大众对心脏健康的认识不断提高，正在推动心血管医疗器械市场的发展。旨在促进心脏健康的教育活动和举措使公众更加了解情况，从而对预防措施和医疗干预措施提出了更高的需求。随着人们越来越意识到与心血管疾病相关的危险因素，他们更有可能寻求医疗建议和治疗。
 
消费者行为的这种转变反映在心血管设备销量的增长上，因为患者积极寻求监测和改善心脏健康的选择。此外，医疗保健提供商正在通过提供更全面的心血管护理解决方案来应对这一趋势，从而扩大市场。对预防保健的重视预计将继续下去，进一步刺激对创新医疗设备的需求。
 

- PubMed 研究表明，预防性心血管筛查和早期干预可显着改善患者的治疗效果，增加对监测和诊断技术的需求。

### Increasing Healthcare Expenditure

各地区医疗保健支出的增长是心血管医疗器械市场的重要驱动力。政府和私营部门正在向医疗保健分配更多资源，心血管护理支出显着增加。报告显示，未来几年医疗保健支出预计将达到数万亿美元，其中很大一部分用于心血管健康。这项财务承诺有助于采用先进的医疗技术和设备，提高为患者提供的护理质量。
 
此外，随着医疗保健系统优先考虑慢性病的管理，对心血管设备的需求可能会增加。这种趋势不仅支持市场的增长，而且鼓励创新，因为公司努力满足医疗保健提供者和患者不断变化的需求。
 

- 全球医疗保健支出持续增长，支持对心血管基础设施、先进技术和慢性病管理解决方案进行更多投资。

### Regulatory Support for Medical Innovations

监管机构越来越多地支持新型心血管医疗器械的开发和批准，这是心血管医疗器械市场的关键驱动力。简化的审批流程和旨在促进创新的举措正在鼓励制造商更快地将新技术推向市场。例如，突破性设备的快速通道的引入大大减少了审批所需的时间，从而可以更快地获得救生技术。
 
这种监管环境不仅增强了制造商之间的竞争，而且刺激了研发投资。因此，市场可能会见证旨在解决各种心血管疾病的创新产品的激增。监管机构的积极立场预计将为行业的整体增长做出积极贡献。
 

- 加速监管途径可以改善突破性心血管设备的获取，鼓励创新并缩短先进技术的上市时间。

### Rising Incidence of Cardiovascular Diseases

心血管疾病患病率的增加是心血管医疗器械市场的主要驱动力。根据最近的统计数据，心血管疾病占全球死亡率的很大一部分，估计占所有死亡人数的近 31%。这种令人震惊的趋势需要开发和部署旨在预防、诊断和治疗的先进医疗设备。
 
随着医疗保健系统努力解决这一日益增长的负担，对创新心血管技术的投资可能会激增。对支架、起搏器和植入式除颤器等设备的需求预计将增加，从而推动市场向前发展。此外，人口老龄化更容易患心脏相关疾病，这增加了有效心血管解决方案的紧迫性，表明该行业的强劲增长轨迹。
 

- 心血管疾病仍然是全球主要死亡原因，每年导致约 1790 万人死亡，从而维持了对先进医疗设备的需求。

###  

### Technological Innovations in Medical Devices

技术进步在塑造心血管医疗器械市场方面发挥着关键作用。 3D 打印、人工智能和远程医疗等创新正在彻底改变心血管疾病的诊断和治疗方式。例如，人工智能与成像技术的集成提高了诊断的准确性，从而实现及时干预。
 
此外，实时监测心脏健康状况的可穿戴设备的开发正在获得关注，对患者和医疗保健提供者都有吸引力。这些设备的市场预计将大幅扩张，预计未来几年的复合年增长率将超过 10%。随着制造商继续投资于研发，预计将推出下一代设备，进一步推动市场增长并改善患者治疗效果。
 

- 支持人工智能的诊断和可穿戴监测系统可提高早期检测准确性并支持长期心血管疾病管理策略。

## Future Outlook

心血管医疗器械市场预计将在2024年至2035年间以3.93%的年均增长率增长，推动因素包括技术进步、心血管疾病的日益普遍以及医疗支出的增加。

**New opportunities:**

- 开发基于人工智能的诊断工具以实现早期检测。 扩展远程医疗服务以进行患者监测。 投资于可生物降解的支架以增强患者安全性。

到2035年，市场预计将实现显著增长，反映出不断变化的医疗保健需求。

## Segment Insights

### 按设备类型：心脏植入物（最大）与诊断成像设备（增长最快）

心血管医疗器械市场呈现出多样化的器械类型，其中心脏植入物占据最大的市场份额，达到52%。这些植入物对于管理各种心血管疾病至关重要，导致新兴市场和发达市场的巨大需求。另一方面，诊断成像设备正在迅速吸引市场兴趣，反映出人们对早期检测和预防性医疗保健的日益重视，这正在成为患者管理的重要组成部分。

美敦力不断创新植入式心血管技术，支持复杂心脏病的治疗。心脏植入物约占**52%市场份额**，由心律失常、心力衰竭的患病率不断增加以及对长期心律管理解决方案的需求推动。

### 按适应症：冠状动脉疾病（最大）与心力衰竭（增长最快）

心血管医疗器械市场在很大程度上受到各种适应症的影响。由于全球心脏病患病率不断上升，冠状动脉疾病 (CAD) 仍然是最大的细分市场，占据 46% 的市场份额。其次是心力衰竭、心律失常和瓣膜性心脏病，这些疾病共同影响了整体市场动态。对早期检测和干预的关注刺激了所有适应症的增长，在研发方面的大量投资促进了创新的设备解决方案。在人口老龄化和医疗保健支出增加的推动下，心力衰竭领域预计将成为心血管医疗器械市场中增长最快的领域。人们对心脏病管理的认识不断提高以及技术的进步正在推动需求。此外，微创治疗方案和可穿戴设备的发展正在导致心律失常和瓣膜性心脏病的增长，因为医疗保健提供者正在寻求针对这些疾病的有效治疗替代方案。

雅培 (Abbott) 开发介入心脏病学技术，满足冠状动脉疾病的治疗需求。 CAD 占据主导地位，几乎**46% 份额**，反映了疾病患病率的增加、人口老龄化以及全球范围内越来越多地采用微创心血管干预措施。

### 按技术分类：可穿戴监测系统（最大）与生物可吸收设备（增长最快）

在心血管医疗设备市场，技术领域表现出很强的多样性，可穿戴监测系统由于越来越多的患者采用它们进行持续健康监测，占据了最大份额，达 55%。与此同时，生物可吸收装置已成为一项有前途的创新，因其在最大限度地减少与永久植入物相关的长期并发症方面的优势而受到关注。这些领域的增长反映了向对患者更友好、更高效的治疗解决方案的转变。

波士顿科学公司通过先进的监测技术支持互联心血管护理。可穿戴监控系统大约可容纳**55%市场份额**，受益于对实时健康跟踪、预防性护理和远程患者监测解决方案不断增长的需求。

### 按最终用户：医院（最大）与家庭医疗机构（增长最快）

在心血管医疗器械市场中，医院占据最大份额，占 64%，是先进心脏手术和干预的主要场所。他们完善的基础设施和熟练的医疗保健专业人员使他们能够利用尖端的心血管技术。门诊手术中心和心脏康复设施也对市场做出了贡献，但程度较小，侧重于特定的心脏手术和康复计划。随着医疗保健系统的发展，这些部分变得越来越重要。最终用户细分市场的增长趋势受到多种因素的影响，包括人口老龄化和心血管疾病患病率的增加。随着远程医疗和远程监控技术的进步使更多患者能够在家管理自己的心血管状况，家庭医疗保健环境正在成为增长最快的领域。向门诊护理的转变反映了患者偏好方便的家庭护理选择的更广泛趋势。

医院（主要）与家庭医疗机构（新兴）

医院是心血管医疗设备市场的主要最终用户，拥有大量用于诊断、治疗和监测心血管疾病的先进医疗设备。他们利用最新技术提供全面护理的能力使他们处于市场的前沿。相比之下，家庭医疗保健环境是一个新兴领域，由于人们对家庭治疗的接受程度不断提高而受到关注。这种转变是由远程监控和远程医疗技术进步推动的，使慢性心血管患者能够在传统医院环境之外接受护理。家庭医疗保健可以提高患者的依从性和舒适度，使其成为对许多人有吸引力的选择。随着法规的发展和技术的不断改进，这两个领域的重要性在未来几年可能会增加。

### 按报销模式：按服务收费（最大）与基于价值的采购（增长最快）

在心血管医疗器械市场，报销模式以按服务付费为主，继续占据最大市场份额，达61%。这种传统的支付系统向医疗保健提供者支付每项服务的费用，使其受到许多从业者的青睐。另一方面，基于价值的采购正在获得提供商和付款人的青睐，因为它强调患者的治疗结果和效率，尽管与按服务付费相比，它目前所占的份额较小。随着市场的发展，捆绑支付和基于价值的购买模式发生了显着的转变。这些趋势是由不断增加的降低医疗成本、同时提高质量和结果的压力推动的。越来越多的医疗保健利益相关者现在认识到投资基于价值的模式的长期好处，创造一个竞争格局，其中灵活性和以患者为中心的护理对于增长至关重要。

按服务收费（主导）与基于价值的采购（新兴）

按服务付费仍然是心血管医疗器械市场的主导报销模式，因为它允许提供者为所使用的每个程序或设备获得直接付款。这种模式虽然被广泛接受，但也因可能刺激服务的过度利用而受到批评。相比之下，基于价值的采购是一种新兴方法，重点关注治疗的实际结果而不是提供的服务量。随着对患者满意度和有效护理的日益重视，该模式奖励医疗保健提供者为患者取得更好的健康结果，从而将财务激励与优质护理结合起来。随着报销策略的调整，那些采用基于价值的方法的人将利用不断变化的环境。

## Regional Market Share Analysis

### 北美：创新市场领导者

北美在心血管医疗器械市场规模方面处于领先地位，到 2024 年将占全球收入的 40.02% 以上。主要增长动力包括人口老龄化、心血管疾病患病率增加以及技术进步。 FDA 等机构的监管支持也促进了新设备的创新和市场进入，改善了患者护理和治疗效果。 

- 每年约有 805,000 名美国人经历心脏病，这增加了对先进心血管监测、植入式设备和介入治疗技术的需求。

美国是主要贡献者，美敦力（Medtronic）、雅培实验室（Abbott Laboratories）和波士顿科学公司（Boston Scientific）等主要参与者引领市场。竞争格局的特点是这些公司之间的持续创新和战略伙伴关系。先进的医疗基础设施进一步支持了该地区心血管医疗器械的增长。

- GE医疗集团继续推进人工智能心血管成像技术，支持早期诊断和精准治疗计划，加强北美的心血管设备生态系统。

### 欧洲：监管框架促进增长

2024年欧洲心血管医疗器械市场价值152.1亿美元，成为第二大区域市场，占有30%的份额。该地区受益于强大的监管框架，包括医疗器械法规 (MDR)，确保高安全性和有效性标准。医疗保健支出的增加和老年人口的增加以及心血管健康意识的提高是重要的需求驱动因素。 

- 欧洲药品管理局支持监管框架，促进安全采用创新心血管技术，加强欧洲医疗保健系统对先进医疗设备的获取。

该市场的领先国家包括德国、法国和英国，其中 B. Braun Melsungen AG 和 Edwards Lifesciences Corporation 等公司最为著名。竞争格局的特点是关键参与者之间的创新和合作，专注于开发先进技术，以满足患者和医疗保健提供者不断变化的需求。在这些因素的推动下，欧洲市场有望稳步增长。

- 欧洲疾病预防和控制中心 (ECDC) 指出，心血管疾病仍然是整个欧洲的主要健康负担，显着增加发病率和死亡率。预防性筛查计划和先进医疗技术的日益采用正在推动整个医疗保健系统对创新心血管设备的需求。

### 亚太地区：潜力巨大的新兴市场

亚太地区是心血管医疗器械市场的新兴强国，占据全球约20%的市场份额。由于医疗保健投资的增加、心血管疾病意识的提高以及中产阶级人口的不断增长，该地区正在经历快速增长。在有利的政府举措和医疗基础设施投资的支持下，中国和印度等国家正在引领这一增长。 

中国是该地区最大的市场，Terumo Corporation 和 Stryker Corporation 等本地和国际企业做出了重大贡献。竞争格局正在不断变化，重点是创新和可负担性，以满足人们的多样化需求。随着医疗保健服务的改善，对先进心血管设备的需求预计在未来几年将大幅增长。

### 中东和非洲：充满机遇的未开发市场

中东和非洲是心血管医疗器械市场资源丰富的前沿地区，约占全球市场份额的10%。该地区的特点是医疗投资增加和心血管疾病患病率上升。旨在改善医疗基础设施和获取机会的政府举措是关键的增长动力，同时人们对心血管健康的认识不断增强。南非和阿联酋等国家在市场上处于领先地位，其中包括本地和国际参与者。 

竞争格局正在逐渐演变，公司专注于针对该地区独特需求量身定制的创新解决方案。随着医疗保健系统的发展，对心血管医疗器械的需求预计将增长，为市场参与者带来重大机遇。

## Competitive Benchmarking

心血管医疗器械市场目前的特点是动态的竞争格局，受到技术进步、心血管疾病的日益普遍以及日益增长的老龄人口的推动。主要参与者如美敦力（美国）、雅培（美国）和波士顿科学（美国）处于前沿，各自采取不同的战略来增强市场定位。美敦力（美国）通过持续的产品开发，特别是在微创手术方面，强调创新，而雅培（美国）则专注于通过战略收购和合作伙伴关系扩展其产品组合。波士顿科学（美国）似乎正在利用数字化转型举措来改善患者结果和运营效率，共同塑造一个优先考虑创新和以患者为中心解决方案的竞争环境。

市场结构适度分散，既有成熟企业，也有新兴公司争夺市场份额。关键商业策略包括本地化生产以降低成本和优化供应链，这在全球经济波动的背景下尤为相关。这些关键参与者的集体影响力促进了一个竞争氛围，在这里，灵活性和对市场需求的响应至关重要，使得能够提供多样化的产品和服务，以满足各地区的需求。

在2025年8月，美敦力（美国）宣布推出其下一代经导管主动脉瓣置换（TAVR）系统，旨在提高手术效率和患者恢复时间。这一战略举措强调了美敦力在心血管干预领域的创新承诺，可能巩固其在TAVR市场细分中的领导地位。这项先进技术的引入不仅可能改善患者结果，还可能增强美敦力在竞争对手中的竞争优势。

在2025年7月，雅培（美国）扩大了与一家领先的远程医疗提供商的合作，以将远程监测能力整合到其心血管设备中。这一合作关系表明了雅培在数字健康解决方案上的战略重点，这可能增强患者参与度和对治疗方案的遵循。通过利用远程医疗技术，雅培可能正在为满足日益增长的远程患者管理需求做好准备，从而增强其在心血管领域的市场存在。

在2025年9月，波士顿科学（美国）推出了一套新的数字健康工具，旨在改善心力衰竭患者的管理。这一举措反映了波士顿科学在其产品中整合数字解决方案的持续承诺，这可能促进更好的患者监测和结果。这一举措的战略重要性在于其有可能使波士顿科学在一个日益关注技术驱动的医疗解决方案的竞争市场中脱颖而出。

截至2025年10月，心血管医疗器械市场的当前竞争趋势受到数字化、可持续性和人工智能整合的强烈影响。战略联盟变得越来越重要，因为公司寻求增强其技术能力并扩大市场覆盖。展望未来，竞争差异化可能会从传统的基于价格的竞争转向关注创新、先进技术和可靠的供应链，这表明公司在应对市场挑战和机遇时将发生变革性转变。

## Recent News & Developments

- **2024年第二季度：波士顿科学以12亿美元收购Silk Road Medical** 波士顿科学宣布达成一项最终协议，以12亿美元现金收购Silk Road Medical，这是一家开发用于预防颈动脉疾病患者中风的设备的公司。此交易扩展了波士顿科学在血管介入领域的产品组合。
- **2024年第二季度：美敦力获得FDA批准Symplicity Spyral肾去神经系统** 美敦力获得FDA批准其Symplicity Spyral肾去神经系统，这是一种旨在治疗高血压的设备，标志着该公司心血管业务的重要监管里程碑。
- **2024年第一季度：雅培在欧洲推出TriClip经导管三尖瓣修复系统** 雅培宣布在获得CE标志批准后，在部分欧洲市场商业推出其TriClip经导管三尖瓣修复系统，扩展其结构性心脏设备的产品线。
- **2024年第二季度：Shockwave Medical完成对Neovasc Inc.的收购** Shockwave Medical完成了对Neovasc Inc.的收购，该公司专注于难治性心绞痛设备，增强了Shockwave在心血管设备领域的地位。
- **2024年第一季度：FDA批准爱德华生命科学的EVOQUE三尖瓣置换系统** 爱德华生命科学获得FDA批准其EVOQUE三尖瓣置换系统，这是美国首个获得批准的经导管三尖瓣反流治疗方案。
- **2024年第二季度：CardioSignal筹集1500万美元B轮融资以扩展AI驱动的心脏病检测平台** CardioSignal是一家专注于AI驱动心脏病检测的健康科技初创公司，获得1500万美元B轮融资，以加速产品开发并扩展其全球影响力。
- **2024年第一季度：Biotronik宣布与梅奥诊所建立远程心脏监测合作关系** Biotronik与梅奥诊所达成战略合作，旨在推进远程心脏监测解决方案，通过增强数据分析和设备连接性改善患者结果。
- **2024年第二季度：飞利浦推出新的Azurion影像引导治疗平台用于心血管手术** 飞利浦推出其最新的Azurion平台，旨在支持复杂的心血管介入手术，具备先进的影像和工作流程能力，面向医院和专科诊所。
- **2024年第一季度：Terumo在北卡罗来纳州开设新的心血管设备制造设施** Terumo宣布在北卡罗来纳州开设新的制造设施，专注于生产先进的心血管设备，以支持日益增长的需求并扩大其在美国的足迹。
- **2024年第二季度：Shockwave Medical完成2亿美元的公开募股** Shockwave Medical完成了2亿美元的公开募股，以资助其心血管应用的血管内碎石技术的进一步开发和商业化。
- **2024年第一季度：波士顿科学宣布与HeartFlow建立合作关系以推进冠状动脉疾病诊断** 波士顿科学与HeartFlow建立合作关系，旨在将HeartFlow的AI驱动冠状动脉疾病诊断平台与波士顿科学的介入心脏病解决方案整合。
- **2024年第二季度：雅培任命新全球心血管设备部门负责人** 雅培任命Dr. Lisa Chen为其全球心血管设备部门的新负责人，标志着其在创新和国际扩展方面的战略重点。

## Report Scope

| 2024年市场规模 | 50.72（十亿美元） |
| --- | --- |
| 2025年市场规模 | 52.72（十亿美元） |
| 2035年市场规模 | 77.52（十亿美元） |
| 复合年增长率（CAGR） | 3.93%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 人工智能在心血管诊断中的整合提升了患者结果和运营效率。 |
| 关键市场动态 | 技术进步和监管变化推动心血管医疗设备市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 心血管医疗器械市场目前的估值是多少？**
A: 2024年市场估值为507.2亿美元。

**Q: 到2035年，心血管医疗设备市场的预计市场规模是多少？**
A: 预计到2035年，市场将达到775.2亿美元。

**Q: 2025年至2035年，心血管医疗器械市场的预期CAGR是多少？**
A: 预测期内的预期CAGR为3.93%。

**Q: 心血管医疗器械市场包括哪些细分领域？**
A: 关键细分包括设备类型、适应症、技术、最终用户和报销模型。

**Q: 到2035年，心脏植入物的预计收入是多少？**
A: 预计到2035年，心脏植入物的收入将在230亿到300亿美元之间。

**Q: 到2035年，穿戴式监测系统的市场预计将增长多少？**
A: 可穿戴监测系统的市场预计到2035年将增长到152.1亿至250亿美元之间。

**Q: 心血管医疗器械市场的领先公司有哪些？**
A: 主要参与者包括美敦力、雅培、波士顿科学和强生。

**Q: 到2035年，医院作为最终用户的预期收入是多少？**
A: 到2035年，医院预计将产生200亿到300亿美元的收入。

**Q: 到2035年，3D打印技术在市场上的预计收入是多少？**
A: 预计到2035年，3D打印技术的收入将达到203亿至295.2亿美元。

**Q: 在心血管医疗器械市场中，预计哪些报销模型将具有重要意义？**
A: 重要的报销模型包括按服务收费、打包支付和基于价值的采购。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/cardiovascular-medical-device-market-30414*